Neonatologia
OMS revela a chocante extensão da propaganda de fórmulas lácteas.
2 Mai, 2022 | 14:00hComunicado de imprensa: WHO reveals shocking extent of exploitative formula milk marketing – World Health Organization
Conteúdo relacionado: More than half of parents and pregnant women exposed to aggressive formula milk marketing – WHO, UNICEF – World Health Organization
Comentário no Twitter (fio – clique para saber mais)
🆕 WHO report reveals shocking extent of exploitative formula milk marketing
The formula milk industry, valued at US$55 billion, is paying social media platforms & influencers to gain direct access to pregnant women & mothers.#EndExploitativeMarketing
👉https://t.co/0dciNxB0fQ pic.twitter.com/hhAnyp0ueH— World Health Organization (WHO) (@WHO) April 29, 2022
Estudo de fase 2b | Imunização contra o vírus sincicial respiratório durante a gestação.
29 Abr, 2022 | 14:53hPrefusion F Protein–Based Respiratory Syncytial Virus Immunization in Pregnancy – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentário: RSV Prefusion F Protein-Based Immunization Studied in Pregnancy – HealthDay
Comentário no Twitter
In pregnant women, RSVpreF vaccine elicited neutralizing antibody responses with efficient transplacental transfer and without evident safety concerns. https://t.co/r8oktZmBZQ pic.twitter.com/UE7ffxYJW6
— NEJM (@NEJM) April 27, 2022
Estudo randomizado | Cateter nasal de alto fluxo durante entubação endotraqueal neonatal.
29 Abr, 2022 | 14:50hNasal High-Flow Therapy during Neonatal Endotracheal Intubation – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentário: Successful Intubations Up With Nasal High-Flow Therapy in Neonates – HealthDay
Comentário no Twitter
Nasal high-flow therapy during neonatal endotracheal intubation increased the likelihood of successful intubation on the first attempt without physiological instability. https://t.co/JWRgtAcoAN pic.twitter.com/EQdFW6pojF
— NEJM (@NEJM) April 27, 2022
Estudo randomizado | Ventilação oscilatória de alta frequência não invasiva vs. pressão positiva contínua nas vias aéreas vs. ventilação com pressão positiva nasal intermitente como suporte pós-extubação para neonatos prematuros.
28 Abr, 2022 | 12:03hNoninvasive High-Frequency Oscillatory Ventilation vs Nasal Continuous Positive Airway Pressure vs Nasal Intermittent Positive Pressure Ventilation as Postextubation Support for Preterm Neonates in China: A Randomized Clinical Trial – JAMA Pediatrics (gratuito por tempo limitado)
Comentário no Twitter
In this randomized clinical trial, NHFOV and nasal intermittent positive pressure ventilation in neonates provided a small advantage of reduced need for invasive respiratory support when used from extubation and until discharge. https://t.co/qCtNP8Gwj9
— JAMA Pediatrics (@JAMAPediatrics) April 25, 2022
A RCT in @JAMAPediatrics evaluates total duration of mechanical ventilation, need for reintubation, and ventilator-free days after extubation to either NHFOV, NCPAP or NIPPV. https://t.co/krwwMv2Hbr#EBNEOalerts #neoEBM #neotwitter pic.twitter.com/uenwdlZfO4
— Evidence-Based Neo (@EBNEO) April 27, 2022
Regulador de medicamentos do Reino Unido aconselha pacientes e médicos contra o uso de pregabalina durante a gestação em virtude de um possível risco aumentado de malformações congênitas.
25 Abr, 2022 | 12:40hVer também: Pregabalin and risks in pregnancy – Medicines and Healthcare products Regulatory Agency
Fonte: Avoid prescribing pregabalin during pregnancy if possible, says UK drug regulator – The BMJ ($)
Comentário no Twitter
The Medicines and Healthcare Products Regulatory Agency (@MHRAgovuk) has strengthened its warning about avoiding pregabalin during pregnancy after new data showed an increased risk of major congenital malformations associated with the drug https://t.co/ghGvqCqA0C
— The BMJ (@bmj_latest) April 22, 2022
M-A | Doença invasiva por estreptococo do grupo A em gestantes e crianças pequenas.
21 Abr, 2022 | 11:55hComentário convidado: Recognising group A streptococcal disease in pregnancy – The Lancet Infectious Diseases (necessário cadastro gratuito)
Revisão sistemática | Doses repetidas de corticosteroides no pré-natal de mulheres em risco de parto prematuro para melhorar os desfechos neonatais de saúde.
21 Abr, 2022 | 11:53hRevisão de escopo de políticas globais, diretrizes e literatura | Preparação e prontidão para alta pós-parto.
18 Abr, 2022 | 15:05hConteúdos relacionados:
WHO recommendations on maternal and newborn care for a positive postnatal experience.
Putting positive experiences at the center of postnatal care.
M-A | Desfechos perinatais adversos associados com terapia antirretroviral baseada em inibidor de protease em gestantes vivendo com HIV.
14 Abr, 2022 | 17:32hComunicado de imprensa: Protease inhibitors safer than thought for pregnant women with HIV – University of Oxford
Experiências positivas no centro da atenção pós-natal.
11 Abr, 2022 | 12:54hPutting positive experiences at the centre of postnatal care – Evidently Cochrane Blog
Diretriz original: WHO recommendations on maternal and newborn care for a positive postnatal experience.